36C10G26Q0016 Therapeutic Shoes RFI - Info Sheet.pdf

REQUEST FOR INFORMATION

36C10G26Q0016

For

THERAPEUTIC SHOES

NOTICE OF INTENT:

The U.S. Department of Veterans Affairs (VA), through the Office of Procurement, Acquisition and Logistics (OPAL), on behalf of the Veterans Health Administration (VHA) and the Strategic Acquisition Center (SAC), is issuing this Request for Information (RFI) in the hopes of attaining sufficient information for market research purposes.

The VHA is seeking potential vendors from all categories: Large and Small Businesses, to include Service-Disabled Veteran Owned Small Business (SDVOSB) and Veteran Owned Small Business (VOSB) contractor(s) for the production and/or supply of therapeutic shoes.

The objective of this information is to provide market research for the availability of Pricing, Data Analysis, and Coding Contractor (PDAC) approved therapeutic footwear medical/surgical supplies for nationwide usage. PDAC is a Medicare contractor responsible for assigning and providing guidance on proper use of Healthcare Common Procedure Coding System (HCPCS) codes. Certain products require Code Verification Review (CVR) in order to be reimbursed by Medicare and most other payers.

The applicable North American Industry Classification System (NAICS) codes assigned to this procurement will be either 316210 Footwear Manufacturing or 339112 Surgical and Medical Instrument Manufacturing.

The Product Service Code is 6515 Medical and Surgical Instruments, Equipment and Supplies.

The Small Business Administration Size Standards for both of these NAICS is 1,000 employees.

SCOPE

The VA needs to determine:

1. The availability and capability to supply name brand therapeutic footwear in a wide spectrum of styles, sizes and widths for both men and women.

2. The availability/capability of modern styles, to include casual and athletic footwear in multiple color options that meet these minimum requirements:

• Has a full length, heel-to-toe filler that when removed provides a minimum of 3/16 of additional depth used to accommodate custom-molded or customized inserts.

• Is made from leather or other suitable material of equal quality (indicate what other materials and what percentage of each, if applicable).

• Has some form of shoe closure.

• Is available in full and half sizes with a minimum of three widths so that the sole is graded to the size and width of the upper portions of the shoe according to the American Standard Last Sizing Schedule or its equivalent.

The American Last Sizing Schedule is the numerical sizing standard used for shoes in the United States (reference Note 1 and Attachment I).

NOTE 1

Vendor will have replacement inserts available for purchase for each available shoe brand/model. Inserts must meet the requirements set forth by the Centers for Medicare & Medicaid Services (CMS) for A5510/A5512 and devices that are appropriately sized and shaped to allow for simple exchange of inserts with the ones provided as standard with the shoes without trimming or reshaping

NOTE 2

HCPCS Code: A5510 - Description: For diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe.

HCPCS Code: A5512 - Description: For diabetics only, multiple density inserts, direct formed, molded to foot after external heat source of 230 degrees Fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16-inch material of shore a 40 durometer (or higher), prefabricated.

Any model addressed in the response must meet Buy American Act (BAA) compliance or Trade Agreement Act (TAA) compliance. If not, please indicate which footwear models do not.

CLOSING STATEMENT:

In accordance with FAR 15.101(c), responses to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. Responses to this RFI are strictly voluntary and VA will not pay respondents for information provided in response to this RFI. Responses to this RFI will not be returned and respondents will not be notified of the result of the review. Not responding to this RFI does not preclude participation in any future notices, if any issued.

If a Solicitation is issued, it will be synopsized on SAM.gov under Contract Opportunities. This RFI does not restrict the Government's acquisition approach on a future Solicitation.

Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Confidentiality, no proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).

RESPONSE INFORMATION:

Please submit responses to this RFI (to include the industry feedback request and comment within Attachment II) to the Contracting Officer, Anna Norcross, via e-mail at Anna.Norcross@va.gov. Please include a point of contact, company name, business size standard, phone number, e-mail address, website information, and a capability statement in your response to the RFI.

Responses must be received by this office on or before 3:00 PM EST on February 2, 2026, and must reference RFI number: 36C10G26Q0016.

• 36C10G26Q0016 Therapeutic Shoes RFI - Attachment I Sizing Requirements

• 36C10G26Q0016 Therapeutic Shoes RFI - Attachment II Vendor Information

//////////////////////////////LAST LINE / END OF DOCUMENT\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ mailto:Anna.Norcross@va.gov